alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                       1,406,603
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,406,603
<PP&E>                                     189,875,741
<DEPRECIATION>                           (189,875,741)
<TOTAL-ASSETS>                               1,406,603
<CURRENT-LIABILITIES>                        1,406,603
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 1,406,603
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
* This order and judgment is not binding precedent, e xcept under the

doctrines of law of the case, res judicata, and col lateral estoppel. The court generally disfavors the citation of orders and judgments; nevertheless, an order and judgment may be cited under the terms and condi tions of 10th Cir. R. 36.3. 

## F I L E D United States Court of Appeals Tenth Circuit 

### MAY 27 2003 

### PATRICK FISHER Clerk UNITED STATES COURT OF APPEALS FOR THE TENTH CIRCUIT UNITED STATES OF AMERICA,

Plaintiff - Appellant, v. ROBERT WAYNE COOK,

Defendant - Appellee. No. 02-7086 (D.C. No. 02-CR-15-S) (E.D. Oklahoma)

ORDER AND JUDGMENT * Before TACHA , Chief Judge, PORFILIO and BALDOCK , Circuit Judges. After examining the briefs and appellate record, th is panel has determined unanimously to grant the parties’ request for a dec ision on the briefs without oral argument. **See** Fed. R. App. P. 34(f); 10th Cir. R. 34.1(G). The case is therefore ordered submitted without oral argument. The United States appealed from the district court’ s dismissal of the indictment against Robert Wayne Cook for lack of jurisdiction. Subsequently,-2-

the United States filed a motion to dismiss this ap peal. We GRANT the motion to dismiss and DISMISS the appeal. Entered for the Court Deanell Reece Tacha Chief Judge
EXHIBIT 32.1


                           SECTION 1350 CERTIFICATION

         In connection with the Annual Report of National Home Health Care Corp.
(the "Company") on Form 10-K for the year ended July 31, 2005, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"),  I, Steven
Fialkow,  Principal  Executive Officer of the Company,  certify,  pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002 that, to the best of my knowledge:

         (1)      The Report fully  complies  with the  requirements  of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and
         (2)      The information  contained in the report fairly  presents,  in
                  all material respects,  the financial condition and results of
                  operations of the Company.

October 27, 2005

                                                 /s/ Steven Fialkow
                                                 ---------------------------
                                                 Steven Fialkow
                                                 Principal Executive Officer

A signed original of this written statement  required by 18 U.S.C.  Section 1350
has been  provided  to National  Home Health Care Corp.  and will be retained by
National  Home Health Care Corp.  and furnished to the  Securities  and Exchange
Commission or its staff upon request.
I 

112TH CONGRESS 

1ST SESSION H. R. 164 

To amend title 49, United States Code, to direct the National Highway 

Traffic Safety Administration to require the disclosure of information 

relating to the fair market value and safety of damaged motor vehicles. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 5, 2011 

Mr. STEARNS introduced the following bill; which was referred to the 

Committee on Energy and Commerce 

A BILL 

To amend title 49, United States Code, to direct the National Highway Traffic Safety Administration to require 

the disclosure of information relating to the fair market 

value and safety of damaged motor vehicles. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Damaged Vehicle In5 formation Act’’. 


srobinson on DSKHWCL6B1PROD with BILLS
2 

•HR 164 IH

1 SEC. 2. DISCLOSURE OF VEHICLE DAMAGE INFORMATION. 

2 Section 32303 of title 49, United States Code, is 

3 amended by adding at the end the following new sub4 section: 

5 ‘‘(d) DISCLOSURE OF FAIR MARKET VALUE AND

6 SAFETY INFORMATION.—(1) Not later than 270 days 

7 after the date of enactment of this subsection, the Sec8 retary of Transportation, through the National Highway 

9 Traffic Safety Administration, shall issue a regulation re10 quiring all persons who terminate a contract related to a 

11 motor vehicle due to flood or water damage, collision, fire 

12 damage, theft and recovery, or any other circumstance 

13 that adversely affects the fair market value of such motor 

14 vehicle, to disclose to the public in a commercially reason15 able, electronically accessible manner the following infor16 mation for every motor vehicle that has been identified in 

17 such contract: 

18 ‘‘(A) The vehicle identification number of the 

19 motor vehicle. 

20 ‘‘(B) The date of the termination of the con21 tract. 

22 ‘‘(C) The odometer reading of the motor vehicle 

23 on the date of the termination of the contract. 

24 ‘‘(D) Whether, as a result of the incident that 

25 resulted in the termination of the contract, one or 

26 more airbags in the motor vehicle were deployed. 


srobinson on DSKHWCL6B1PROD with BILLS
3 

•HR 164 IH

1 ‘‘(E) The cause of the termination of the con2 tract, including whether such cause was flood or 

3 water damage, collision, fire damage, theft and re4 covery, or another cause. 

5 ‘‘(2) The Secretary shall rely on the private sector 

6 to collect, aggregate, and disclose to the public the fair 

7 market value and safety information described in para8 graph (1) and all such information shall be accessible by 

9 vehicle identification number. 

10 ‘‘(3) For purposes of this subsection, the term ‘per11 son’ includes any individual, company, corporation, asso12 ciation, firm, partnership, society, or any other entity, but 

13 does not include any governmental agency.’’. 

Æ 


srobinson on DSKHWCL6B1PROD with BILLS
Amendment No.2 to License Agreement



 Exhibit 10.25 
  
 AMENDMENT No. 2 TO LICENSE AGREEMENT 
  
 This Amendment to License Agreement (the “Amendment”) is entered into as of June 17, 2004 (“Effective Date”) by and between
Formulation Technologies, L.L.C., a Texas limited liability company, d/b/a PharmaForm with offices at 11400 Burnet Rd., Building 4, Suite 4010, Austin, Texas 78758 (hereinafter, “Licensor”), and Auxilium Pharmaceuticals, Inc., a
Delaware corporation having a principal place of business at 160 W. Germantown Pike, East Norriton, Pennsylvania 19401 (hereinafter “Licensee”). 
  
 RECITALS 
  
 A.    Licensor and Licensee are parties to that certain License Agreement (the “Agreement”), dated as of June 20, 2003, which
provides for the license of certain patents to the licensees as set forth therein. 
  
 B.    The Parties to the Agreement desire to amend the Agreement to revise the definition of “Term” and otherwise modify the terms of the Agreement in accordance with the terms of this Amendment.

  
 AGREEMENT 
  
 Accordingly, in consideration of the foregoing and the covenants and agreements contained herein, the parties hereto agree as follows:

  
 1.    Definitions. Capitalized terms used
herein and not otherwise defined herein shall have the meanings set forth in the Agreement. 
  
 2.    Amendments to the Agreement. 
  
 a.    Section 13.1 of the Agreement is hereby amended in its entirety to read as follows: 
  
 “Term:    This Agreement and the licenses granted herein shall
commence on the Effective Date and shall continue subject to earlier termination as provided herein, until the expiration of the Patent (as identified in the definition of Licensed Technology in Article I of the Agreement). (the
“Term”)” 
  
 3.    Governing Law.
The construction, validity and interpretation of this Amendment shall be governed by the internal laws of the State of Delaware without reference to the choice of law provisions thereof. 
  
 4.    Severability. The invalidity or unenforceability of any provision of this Amendment shall not affect
the validity or enforceability of any other provision of this Amendment. 
  
 5.    Counterparts. This Amendment may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall be one and the same document. 







 6.    Continuation of the Agreement. Except as specifically amended herein, the
Agreement is and shall continue to be in full force and effect and is hereby in all respects ratified and confirmed. 
  
 IN WITNESS WHEREOF, this Amendment has been executed by the parties hereto as of the date first written above. 
  
  

			
	 LICENSOR

	
	 Formulation Technologies, L.L.C.

		
	 By:
	 	 /s/    James W. McGinity


		
	 Name:
	 	 James W. McGinity


		
	 Title:
	 	 Chief Executive Officer


	
	 LICENSEE

	
	 Auxilium Pharmaceuticals, Inc.

		
	 By:
	 	 /s/ Jane H. Hollingsworth


		
	 Name:
	 	 Jane H. Hollingsworth


		
	 Title:
	 	 Executive Vice President, Secretary 
and General Counsel
# Fourth Court of Appeals

San Antonio, Texas

November 17, 2021

No. 04

- 21

- 00299

- CV

IN RE Douglas C. GLENEWINKEL and Ward A. Glenewinke l,

From the 456th District Court

, Guadalupe County, Texas

Trial Court No. 210

- 921

- CV

- E

Honorable Heather H. Wright , Judge Presiding



### O R D E R

Sitting: Rebeca C. Martinez, Chief Justice

Irene Rios, Justice

Liza A . Rodriguez, Ju stice

On October 14, 2021, relators filed a Motion for Rehearing. After consideration, the

motion is DENIED

.

I t is so ORDE RED on this 17th day of November, 2021

.

PER CURIAM

ATTESTED TO:

_______________________________

MICHAEL A. CRUZ

, Clerk of Court
<TABLE> <S> <C>


<ARTICLE>                                     5

<MULTIPLIER>                                  1

<CURRENCY>                         U.S. DOLLARS

<S>                                         <C>
<PERIOD-TYPE>                            12-MOS
<FISCAL-YEAR-END>                   DEC-31-1999
<PERIOD-START>                      JAN-01-1999
<PERIOD-END>                        DEC-31-1999
<EXCHANGE-RATE>                               1
<CASH>                                  370,527
<SECURITIES>                                  0
<RECEIVABLES>                           874,917
<ALLOWANCES>                             16,000
<INVENTORY>                           1,519,277
<CURRENT-ASSETS>                      2,938,845
<PP&E>                                2,088,005
<DEPRECIATION>                          963,422
<TOTAL-ASSETS>                        4,298,779
<CURRENT-LIABILITIES>                   671,888
<BONDS>                                       0
<PREFERRED-MANDATORY>                         0
<PREFERRED>                                   0
<COMMON>                                 12,486
<OTHER-SE>                            2,403,671
<TOTAL-LIABILITY-AND-EQUITY>          4,298,779
<SALES>                               5,670,600
<TOTAL-REVENUES>                      5,670,600
<CGS>                                 2,633,510
<TOTAL-COSTS>                         2,633,510
<OTHER-EXPENSES>                      2,265,916
<LOSS-PROVISION>                              0
<INTEREST-EXPENSE>                      111,738
<INCOME-PRETAX>                         715,305
<INCOME-TAX>                            292,000
<INCOME-CONTINUING>                     423,305
<DISCONTINUED>                                0
<EXTRAORDINARY>                               0
<CHANGES>                                     0
<NET-INCOME>                            423,305
<EPS-BASIC>                                 .34
<EPS-DILUTED>                               .31



</TABLE>
Order entered September 23, 2022

In The 

### Court of Appeals Fifth District of Texas at Dallas

No. 05

- 22

- 00798

- CV

AMOS HEARD, R.N. AND EMINENT MEDICAL CENTER, LLC , Appellant s

V.

APRIL ROBLES, R.N. , A ppellee

On Appeal from the 192nd Judicial District Court

Dallas County, Texas Trial Court Cause No. DC

- 21

- 04495

O RDER

Before the Court is appellant Eminent Medical Center, LLC’s September 22,
2022 unopposed motion for an extension of time to file its br ief on the merits. 1 We

GRANT the motion and extend the time to October 3, 2022

. Also before the Court is appellee’s September 22, 2022 motion for an
extension of time to file her brief. We GRANT the motion and extend the time to
October 24, 2022

. /s/ B ONNIE LEE GOLDSTEIN JUSTICE

1 Appellant Amos Heard, R.N. has filed his brief.
The State of



# Fourth Court of Appeals

**San Antonio, Texas**

October 23, 2015

N o. 04

- 15

- 00299

- CR

Louis Leo CHRISTINA

, Appellant

v.

The STATE of Texas

, Appellee

From the 186th Judicial District Court, Bexar County, Texas

Trial Court No. 2012CR4887

Honorable Jefferson Moore, Judge Presiding



### ORDER

Appellant’s second motion for extension of time to file his brief is GRANTED.

Appellant’s brief is due on Novembe r 12, 2015

.

_________________________________ Karen Angelini, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of th e said

court on this 23rd day of October, 2015

.

___________________________________ Keith E. Hottle

Clerk of Court
EXHIBIT 31.1



CERTIFICATION PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002



I, Andrew Rackear, certify that:



| | 1. | I have reviewed this Amendment No. 1 on Form 10-K/A for
the fiscal year ended December 31, 2017 of Enzon Pharmaceuticals, Inc.; and
| | -- | -----------------------------------------------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this Amendment No. 1 on Form 10-K/A
does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
Amendment No. 1 on Form 10-K/A.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|April 25, 2018 | /s/ Andrew Rackear                   
|-------------- | -------------------------------------
|               | Andrew Rackear                       
|               | Chief Executive Officer and Secretary
|               | (Principal Executive Officer)
* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not be

published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

June 30, 2003

Charles R. Fulbruge III

Clerk

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 02-60800

Summary Calendar

 

DARRELL GLENN,

 Plaintiff-Appellant,

versus

CITY OF COLUMBUS, MISSISSIPPI; ET AL,

 

Defendants,

CITY OF COLUMBUS, MISSISSIPPI; 

LOWNDES COUNTY MISSISSIPPI,

 DefendantsAppellees.

------------------------------------------------------

Appeal from the United States District Court

for the Northern District of Mississippi

USDC No. 1:01-CV-235-D

-------------------------------------------------------

Before DAVIS, STEWART and DENNIS, Circuit Judges.

PER CURIAM:*

DarrellGlenn appealsthe district court’sfinal judgment granting the defendants’ motions for

summary judgment and dismissing the case with prejudice. 
-2-

Glenn arguesthat there are issues of materialfact asto whether the city of Columbusisliable

for his arrest without probable cause. Glenn’s complaint raised a wrongful arrest claim against only

the individual defendant who was voluntarily dismissed and not against Columbus. This court will

not consider an issue based on a theory that Glenn did not assert in the district court. See Levertte

v. Louisville Ladder Co., 183 F.3d 339, 342 (5th Cir. 1999).

Glenn argues that Columbus’ use of a master bond schedule is a violation of the Eighth

Amendment’s Excessive Bail Clause. Glenn additionally argues that the requiring him to pay 10%

of the bail amount to a bail bondsman without allowing him the opportunity to be heard by an

impartial officer violates the Due Process Clause. 

Because it was used inconjunctionwithother meaningful alternatives provided bythe relevant

Mississippistatutes, Columbus’ use of the bond schedule does not violate the Excessive BailClause.

See Pugh v. Rainwater, 572 F.2d 1053, 1057 (5th Cir. 1978) (en banc). For similar reasons,

Columbus’ use of the bond schedule does not violate the Due Process Clause. See Pugh, 572 F.2d

at 1057. Mississippi provides that, upon arrest for a misdemeanor, an arrestee may demand to appear

before a judicial officer; however, Glenn made no such demand. See MISS. CODE ANN. 

§ 99-3-18(1). The defendants were not required to provide Glenn with a hearing before a judicial

officer immediately upon the completion of booking during the early morning hours on a Sunday,

when such an official was not readily available. See County of Riverside v. McLaughlin, 500 U.S.

44, 56-57 (1991). Accordingly, there was no denial of due process.

AFFIRMED.
CONSENT OF INDEPENDENT ACCOUNTANTS


     We consent to the incorporation by reference in the Registration Statements
of Scios  Inc.  on Forms S-8  (File  No.  2-90477,  File No.  2-97606,  File No.
33-39878 and File No.  33-51590) and Form S-3 (File No.  33-18958) of our report
dated January 29, 1997 on our audits of the consolidated financial statements of
Scios Inc. and subsidiaries as of December 31, 1996 and 1995 and for each of the
three years in the period  ended  December  31, 1996 which report is included in
this Annual Report of Form 10-K.



Coopers & Lybrand L.L.P.
San Jose, California
March 28, 1997














                                  EXHIBIT 23.1
IB 

Union Calendar No. 144 

112TH CONGRESS 

1ST SESSION H. R. 1560 

[Report No. 112–222] 

To amend the Ysleta del Sur Pueblo and Alabama and Coushatta Indian 

Tribes of Texas Restoration Act to allow the Ysleta del Sur Pueblo 

Tribe to determine blood quantum requirement for membership in that 

tribe. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 14, 2011 

Mr. REYES introduced the following bill; which was referred to the Committee 

on Natural Resources 

SEPTEMBER 23, 2011 

Committed to the Committee of the Whole House on the State of the Union 

and ordered to be printed 


sroberts on DSK5SPTVN1PROD with BILLS
2 

•HR 1560 RH

A BILL 

To amend the Ysleta del Sur Pueblo and Alabama and 

Coushatta Indian Tribes of Texas Restoration Act to 

allow the Ysleta del Sur Pueblo Tribe to determine blood 

quantum requirement for membership in that tribe. 


sroberts on DSK5SPTVN1PROD with BILLS
3 

•HR 1560 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. BLOOD QUANTUM REQUIREMENT DETER4 MINED BY TRIBE. 

5 Section 108(a)(2) of the Ysleta del Sur Pueblo and 

6 Alabama and Coushatta Indian Tribes of Texas Restora7 tion Act (25 U.S.C. 1300g–7(a)(2)) is amended to read 

8 as follows: 

9 ‘‘(2) any person of Tigua Ysleta del Sur Pueblo 

10 Indian blood enrolled by the tribe.’’. 


sroberts on DSK5SPTVN1PROD with BILLS
Union Calendar No. 144 

112TH CONGRESS 

1ST SESSION H. R. 1560 

[Report No. 112–222] 

A BILL 

To amend the Ysleta del Sur Pueblo and Alabama 

membership in that tribe. to determine blood quantum requirement for tion Act to allow the Ysleta del Sur Pueblo Tribe and Coushatta Indian Tribes of Texas RestoraSEPTEMBER 23, 2011 

Committed to the Committee of the Whole House on the 

State of the Union and ordered to be printed 


sroberts on DSK5SPTVN1PROD with BILLS